Targeted drug therapy shows promise for ulcerative colitis remission

An international placebo-controlled study led by Cedars-Sinai suggests that a targeted drug therapy that was developed by researchers at Cedars-Sinai is safe and effective at helping people with moderate to severe ulcerative colitis reach clinical remission.

Farxiga OK’d for Kids; Semaglutide Price Hearing; Maintaining GLP-1 Weight Loss

The FDA approved dapagliflozin (Farxiga) for glycemic control in children ages 10 years and older with type 2 diabetes, based on results from the phase

June 19, 2024

Court adviser sides with Illumina in EU row that triggered Grail fine

Dive Brief: Illumina may avoid an approximately 432 million euro fine related to its Grail takeover after an adviser to the Court of Justice of

March 25, 2024

Pα+ Psychedelic Bulletin #149: Worldwide Psychedelic Policy Developments – Psychedelic Alpha

This issue’s contents: California: TREAT Retreats and Wiener Regroups, While Psilocybin Decrim. Initiative Continues Collecting Signatures Veterans’ Affairs Subcommittee on Health Discusses Psychedelics Canadian Senate’s

November 17, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.